Results 171 to 180 of about 5,434,736 (260)
Pathophysiological Drivers of Mast Cell Activation Syndrome and Implications for Treatment. [PDF]
Collins S +3 more
europepmc +1 more source
WTAP‐Mediated m6A Modification of TXNDC5 mRNA Promotes Cervical Carcinogenesis
ABSTRACT WT1‐associated protein (WTAP), a core component of the methyltransferase complex, is involved in various tumor pathological processes, but its specific mechanism in cervical cancer (CC) remains unclear. This study, based on single‐cell transcriptomic data (including 3 CC and 2 normal tissues), constructed a CC microenvironment cell atlas ...
Ling Chen +4 more
wiley +1 more source
Examining the immunomodulatory role of nanoparticles on mast cell activation. [PDF]
Pineda JP, DeLouise LA.
europepmc +1 more source
ABSTRACT This study aimed to elucidate the role of the RNA‐binding protein embryonic lethality abnormal vision‐like protein 1 (ELAVL1) in the pathogenesis of allergic rhinitis (AR), specifically by investigating its potential to promote T helper 2 (Th2) cell differentiation by regulating the stability of carboxypeptidase A3 (CPA3) mRNA.
Meng‐Ya Liu +2 more
wiley +1 more source
Exploring mast cell phenotype and functions during tumor progression
Introduction Mast cells (MCs) infiltrate both human and mouse colorectal cancer (CRC) lesions but their role in tumor progression is still controversial.
Erisa Putro +6 more
core
Cutaneous mast cell tumors in dogs: Association with gonadectomy. [PDF]
Sollier Podestá F +4 more
europepmc +1 more source
ABSTRACT Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent synovial inflammation and progressive joint damage. Although ferroptosis has been implicated in RA progression, the role of disulfidptosis and its interaction with ferroptosis remains unclear.
Ting‐Ting Wang +10 more
wiley +1 more source
The Characteristics of 924 Cutaneous Mast Cell Tumours in Dogs ≤ 3 Years of Age-With a Short Literature Review of Feline, Equine, and Human Proliferative Mast Cell Disorders. [PDF]
Schwinn J +4 more
europepmc +1 more source
Therapeutic JAK Inhibition in Idiopathic Subglottic Stenosis
Three patients with idiopathic subglottic stenosis and rheumatoid arthritis began JAK inhibitor therapy, after which the mean surgical‐free interval between endoscopic dilations rose from 317 to 631 days and the annualized dilation rate fell from 1.24 to 0.38 per patient‐year. Figure 2 shows this as a per‐patient timeline.
Riley M. Larkin +5 more
wiley +1 more source
Disseminated cutaneous mast cell tumor in a South American coati (Nasua nasua). [PDF]
Mazaro RD +6 more
europepmc +1 more source

